Additional file 1 of Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

Oh, Do-Youn; Maqueda, Maria Alsina; Quinn, David I.; O’Dwyer, Peter J.; Chau, Ian; Kim, Sun Young; Duran, Ignacio; Castellano, Daniel; Berlin, Jordan; Mellado, Begona; Williamson, Stephen K.; Lee, Keun-Wook; Marti, Francisca; Mathew, Paul; Saif, Muhammad Wasif; Wang, Ding; Chong, Elizabeth; Hilger-Rolfe, Jacqueline; Dean, James P.; Arkenau, Hendrik-Tobias

doi:10.6084/m9.figshare.24494194.v1

12885_2023_11539_MOESM1_ESM.docx (24.2 kB)

Additional file 1 of Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

journal contribution

posted on 2023-11-03, 04:41 authored by Do-Youn Oh, Maria Alsina Maqueda, David I. Quinn, Peter J. O’Dwyer, Ian Chau, Sun Young Kim, Ignacio Duran, Daniel Castellano, Jordan Berlin, Begona Mellado, Stephen K. Williamson, Keun-Wook Lee, Francisca Marti, Paul Mathew, Muhammad Wasif Saif, Ding Wang, Elizabeth Chong, Jacqueline Hilger-Rolfe, James P. Dean, Hendrik-Tobias Arkenau

Additional file 1: Supplementary Methods. Follow-up. Supplementary Methods. Maximum tolerated dose. Supplementary Methods. Dose adjustment guidelines. Supplementary Table S1. Prior therapies